EP1261639A2 - Peptide apparente a la chondromoduline-i - Google Patents

Peptide apparente a la chondromoduline-i

Info

Publication number
EP1261639A2
EP1261639A2 EP01908629A EP01908629A EP1261639A2 EP 1261639 A2 EP1261639 A2 EP 1261639A2 EP 01908629 A EP01908629 A EP 01908629A EP 01908629 A EP01908629 A EP 01908629A EP 1261639 A2 EP1261639 A2 EP 1261639A2
Authority
EP
European Patent Office
Prior art keywords
polypeptide
chmirp
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01908629A
Other languages
German (de)
English (en)
Inventor
Hung Nguyen
Jeannie Jung
Kristie Clarkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of EP1261639A2 publication Critical patent/EP1261639A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un nouveau polynucléotide codant un polypeptide dont la structure est proche de celle de la chondromoduline-I, ainsi que la protéine purifiée elle-même. Cette invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés de recombinaison qui permettent de produire les polypeptides, ainsi que des applications dans les domaines de la thérapie, du diagnostic et de la recherche pour ces produits et les produits apparentés.
EP01908629A 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i Withdrawn EP1261639A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US724310 1991-06-28
US17689800P 2000-01-19 2000-01-19
US176898P 2000-01-19
US72431000A 2000-11-28 2000-11-28
PCT/US2001/001700 WO2001053344A2 (fr) 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i

Publications (1)

Publication Number Publication Date
EP1261639A2 true EP1261639A2 (fr) 2002-12-04

Family

ID=26872727

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01908629A Withdrawn EP1261639A2 (fr) 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i

Country Status (7)

Country Link
EP (1) EP1261639A2 (fr)
JP (1) JP2003520590A (fr)
AR (1) AR027238A1 (fr)
AU (1) AU3647701A (fr)
CA (1) CA2398695A1 (fr)
MX (1) MXPA02007119A (fr)
WO (1) WO2001053344A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE463510T1 (de) 1999-09-29 2010-04-15 Teijin Ltd Polypeptide und für diese kodierende gene

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
WO2001016318A2 (fr) * 1999-09-01 2001-03-08 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
WO2000078961A1 (fr) * 1999-06-23 2000-12-28 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
EP1068312A2 (fr) * 1998-04-09 2001-01-17 Genset Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
NZ531664A (en) * 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
WO2000029579A1 (fr) * 1998-11-13 2000-05-25 Zymogenetics, Inc. Proteine de type chondromoduline de mammmifere
EP1144614A4 (fr) * 1999-01-19 2003-08-06 Human Genome Sciences Inc Proteines humaines secretees (33)
ATE463510T1 (de) * 1999-09-29 2010-04-15 Teijin Ltd Polypeptide und für diese kodierende gene
JP2001299363A (ja) * 1999-12-27 2001-10-30 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ
WO2001048203A1 (fr) * 1999-12-27 2001-07-05 Takeda Chemical Industries, Ltd. Nouvelle proteine et adn associe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0153344A2 *

Also Published As

Publication number Publication date
AR027238A1 (es) 2003-03-19
WO2001053344A2 (fr) 2001-07-26
AU3647701A (en) 2001-07-31
JP2003520590A (ja) 2003-07-08
WO2001053344A3 (fr) 2002-01-03
CA2398695A1 (fr) 2001-07-26
MXPA02007119A (es) 2003-04-14

Similar Documents

Publication Publication Date Title
US20040146888A1 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
US6521422B1 (en) Fhm, a novel member of the TNF ligand supergene family
US20050277151A1 (en) NTR3, a novel member of the TNF- receptor supergene family
US20080241154A1 (en) Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family
AU2001279024B2 (en) C3b/C4b complement receptor-like molecules and uses thereof
AU2001251082B2 (en) CD20/IgE-receptor like molecules and uses thereof
US20030096355A1 (en) Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU2001251082A1 (en) CD20/IgE-receptor like molecules and uses thereof
WO2001053344A2 (fr) Peptide apparente a la chondromoduline-i
AU2006200794A1 (en) Fhm, A novel member of the TNF ligand supergene family
US20060168672A1 (en) B7-like molecules and uses thereof
AU2006202629A1 (en) Chondromodulin-I Related Peptide
WO2001068852A2 (fr) Regulation apo-a-i de la signalisations des lymphocytes t
EP1268782A2 (fr) Regulation apo-a-i de la signalisations des lymphocytes t
AU2007200628A1 (en) Cystine-Knot Polypeptides: Cloaked-2 Molecules and Uses Thereof
AU2007201047A1 (en) CD20/lgE-Receptor Like Molecules and Uses Thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020819

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020819;LT PAYMENT 20020819;LV PAYMENT 20020819;MK PAYMENT 20020819;RO PAYMENT 20020819;SI PAYMENT 20020819

17Q First examination report despatched

Effective date: 20031107

17Q First examination report despatched

Effective date: 20031107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080924